GB0222945D0 - Therapeutic compositions - Google Patents

Therapeutic compositions

Info

Publication number
GB0222945D0
GB0222945D0 GBGB0222945.8A GB0222945A GB0222945D0 GB 0222945 D0 GB0222945 D0 GB 0222945D0 GB 0222945 A GB0222945 A GB 0222945A GB 0222945 D0 GB0222945 D0 GB 0222945D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0222945.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psimei Pharmaceuticals PLC
Original Assignee
Psimei Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals PLC filed Critical Psimei Pharmaceuticals PLC
Priority to GBGB0222945.8A priority Critical patent/GB0222945D0/en
Publication of GB0222945D0 publication Critical patent/GB0222945D0/en
Priority to AU2003260793A priority patent/AU2003260793A1/en
Priority to PCT/GB2003/003870 priority patent/WO2004030661A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
GBGB0222945.8A 2002-10-03 2002-10-03 Therapeutic compositions Ceased GB0222945D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0222945.8A GB0222945D0 (en) 2002-10-03 2002-10-03 Therapeutic compositions
AU2003260793A AU2003260793A1 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound
PCT/GB2003/003870 WO2004030661A2 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0222945.8A GB0222945D0 (en) 2002-10-03 2002-10-03 Therapeutic compositions

Publications (1)

Publication Number Publication Date
GB0222945D0 true GB0222945D0 (en) 2002-11-13

Family

ID=9945241

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0222945.8A Ceased GB0222945D0 (en) 2002-10-03 2002-10-03 Therapeutic compositions

Country Status (3)

Country Link
AU (1) AU2003260793A1 (en)
GB (1) GB0222945D0 (en)
WO (1) WO2004030661A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863484B1 (en) * 2003-12-11 2007-04-13 Oreal USE OF COMPOUNDS CAPABLE OF ACTING ON THE METABOLIC PATHWAY CONTROLLED BY DOPACHROME TAUTOMERASE TRP-2 AS PROTECTIVE AGENT OF MELANOCYTES OF FOLLICLE AND APPLICATIONS
GB0404708D0 (en) * 2004-03-02 2004-04-07 Cellic As T Boron containing nanoparticles
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
BR112019020991B1 (en) 2017-04-07 2024-01-23 North Carolina State University COMPOSITION COMPRISING POLYMER, ALDARIC ACID AND ADDITIVE, METHOD FOR PRODUCING THE SAME AND CONCRETE ADDITIVE AND FIBROUS ARTICLE COMPRISING THE COMPOSITION
CN111117124B (en) * 2018-10-30 2021-02-12 华南理工大学 Hot water soluble polyvinyl alcohol film and preparation method and application thereof
KR102562968B1 (en) * 2018-11-01 2023-08-04 주식회사 셀비온 p-Boronophenylalanine composition for Boron Neutron Capture Therapy and preparing method thereof
EP3960204A4 (en) * 2019-04-26 2022-07-06 Neuboron Medtech Ltd. Bpa lyophilized preparation and preparation method therefor
CN114364401A (en) * 2019-09-12 2022-04-15 斯特拉制药公司 Method for preventing precipitation of injection containing boronophenylalanine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
US6169076B1 (en) * 1999-03-31 2001-01-02 Glcosyn Pharmaceuticals, Inc. P-Boronophenylalanine complexes with fructose and related carbohydrates and polyols

Also Published As

Publication number Publication date
AU2003260793A8 (en) 2004-04-23
WO2004030661A3 (en) 2004-09-30
AU2003260793A1 (en) 2004-04-23
WO2004030661A2 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
GB0212062D0 (en) Jetable compositions
EP1603543A4 (en) Therapeutic compositions
IL165372A0 (en) Immunodenic compositions
GB0224415D0 (en) Compositions
GB2391473B (en) Pharmaceutical compositions
EP1608385A4 (en) Therapeutic compositions
EP1556023A4 (en) Nutritional or therapeutic compositions
AU2003279911A8 (en) Therapeutic formulations
GB0208609D0 (en) Compositions
GB2392618B (en) Compositions for therapeutic use
GB0229258D0 (en) Medicinal compositions
GB0221894D0 (en) Compositions
AU2003269904A8 (en) Antigen-polymer compositions
GB0222945D0 (en) Therapeutic compositions
AU2002365093A8 (en) Therapeutic compositions
AU2003215150A8 (en) Therapeutic compounds
AU2003282722A8 (en) Therapeutic compositions
GB0203395D0 (en) Compositions
GB0213481D0 (en) Pharmaceutical compositions
HK1081451A1 (en) Medicinal composition
GB0203396D0 (en) Compositions
GB0109428D0 (en) Therapeutic compositions
GB0317524D0 (en) Compositions
HK1062274A1 (en) Medicinal composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)